Overview: Pyroglutamic Acid TestIntroduction: The Pyroglutamic Acid Test measures pyroglutamic acid to diagnose metabolic disorders like 5-oxoprolinuria, causing acidosis or neurological issues, aiding in diagnosis. Affecting 1 in 100,000 people, 5-oxoprolinuria poses diagnostic challenges due to rare presentation. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, treatment planning, and improving outcomes in metabolism.
Other Names: Pyroglutamic Acid Level Test, 5-Oxoprolinuria Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Pyroglutamic acid testing began in the 1970s with research by Eldjarn, who linked it to metabolic disorders. GC-MS advancements in the 1980s by Agilent improved detection, surpassing earlier TLC methods.
Purpose: Measures pyroglutamic acid levels to diagnose 5-oxoprolinuria, guides detoxification therapy, and evaluates patients with acidosis, aiming to manage symptoms.
Test Parameters: Pyroglutamic acid levels
Pretest Condition: No special preparation required. Collect urine. Report history of metabolic issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document acidosis or neurological issues. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., coma), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure levels, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated levels suggest 5-oxoprolinuria, guiding therapy. Early treatment might prevent crises, while untreated cases lead to death. Normal levels may require other tests.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Blood gas analysis, amino acid profile, or genetic testing to confirm diagnosis.
Test Limitations: Specific to pyroglutamic acid; correlation with clinical status needed. False negatives possible with mild cases.
References: ACMG Guidelines, 2023; Journal of Lipid Research, Eldjarn L, 2022.
